Kiora Pharmaceuticals, Inc.
Kiora Pharmaceuticals, Inc. (KPRX) Stock Ownership
Latest 13F position summary is not yet available — breakdown and tables fill in after filings publish (typically ~45 days after quarter end).
SEC 13F · FMP · KPRX · as of —
Ownership Breakdown
Institutional data for this period is not yet available. SEC Form 13F filings are typically published 45 days after quarter end.
No institutional data available for this period.
Insider Buying vs Selling
KPRX insider trading · insider activity
Source: SEC Form 4
0
Buy transactions
3
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Tosca Melissa CFO | Apr 1, 2026 | Tax Withhold | 929 | $1.95 | $1.8K | 27.0K | Form 4 ↗ |
Daniels Eric Joseph Chief Development Officer | Apr 1, 2026 | Tax Withhold | 929 | $1.95 | $1.8K | 31.7K | Form 4 ↗ |
Strem Brian M. President and CEO | Apr 1, 2026 | Tax Withhold | 1,906 | $1.95 | $3.7K | 60.7K | Form 4 ↗ |
Daniels Eric Joseph Chief Development Officer | Mar 6, 2026 | Award | 6,533 | — | — | 32.7K | Form 4 ↗ |
Daniels Eric Joseph Chief Development Officer | Mar 6, 2026 | Award | 13,067 | $1.98 | $25.9K | 13.1K | Form 4 ↗ |
Strem Brian M. President and CEO | Mar 6, 2026 | Award | 16,733 | — | — | 62.6K | Form 4 ↗ |
Strem Brian M. President and CEO | Mar 6, 2026 | Award | 33,467 | $1.98 | $66.3K | 33.5K | Form 4 ↗ |
Tosca Melissa CFO | Mar 6, 2026 | Award | 6,533 | — | — | 27.9K | Form 4 ↗ |
Tosca Melissa CFO | Mar 6, 2026 | Award | 13,067 | $1.98 | $25.9K | 13.1K | Form 4 ↗ |
Daniels Eric Joseph Chief Development Officer | Mar 3, 2026 | Tax Withhold | 238 | $2.02 | $480.76 | 26.1K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Kiora Pharmaceuticals, Inc. (KPRX) is primarily owned by institutional investors, who hold approximately — of total shares outstanding. Company insiders own approximately —, while retail and public investors account for the remaining —.
A total of 0 institutional investors currently hold KPRX stock, with a combined institutional value of approximately $0 as of the most recent 13F filing period.
Frequently asked questions
KPRX ownershipKiora Pharmaceuticals, Inc. (KPRX) is primarily owned by institutional investors, who hold approximately — of shares. The largest shareholder is — with a — stake. Company insiders hold —. Data sourced from SEC Form 13F as of —.